How big is the gastro esophageal reflux disease gerd drug market?

Q: How big is the gastro esophageal reflux disease gerd drug market?

Market Analysis and Insights Global Gastro Esophageal Reflux Disease GERD Drug MarketDue to the COVID19 pandemic the global Gastro Esophageal Reflux Disease GERD Drug market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

Global Gastro Esophageal Reflux Disease (GERD) Drug Market Insights and Forecast to 2028

Code: QYRE-Auto-15V9374

Report

January 2022

Pages:106

QYResearch

Description

Table of Content

Tables & Figures

FEATURED COMPANIES

Takeda Pharmaceutical Company Limited

Market Analysis and Insights: Global Gastro Esophageal Reflux Disease (GERD) Drug Market

Due to the COVID-19 pandemic, the global Gastro Esophageal Reflux Disease (GERD) Drug market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period.

Fully considering the economic change by this health crisis, H2 Receptor Antagonist accounting for % of the Gastro Esophageal Reflux Disease (GERD) Drug global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Hospital segment is altered to an % CAGR throughout this forecast period.

China Gastro Esophageal Reflux Disease (GERD) Drug market size is valued at US$ million in 2021, while the US and Europe Gastro Esophageal Reflux Disease (GERD) Drug are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Gastro Esophageal Reflux Disease (GERD) Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

The global key manufacturers of Gastro Esophageal Reflux Disease (GERD) Drug include Pfizer, Novartis AG, GlaxoSmithKline, Merck, Medtronic, The Kroger Co., Aros Pharma, AstraZeneca, Plc. and Addex Therapeutics and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

Global Gastro Esophageal Reflux Disease (GERD) Drug Scope and Segment

Gastro Esophageal Reflux Disease (GERD) Drug market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Gastro Esophageal Reflux Disease (GERD) Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

H2 Receptor Antagonist

Proton Pump Inhibitor (PPi)

Antacids

Segment by Application

Hospital

Clinic

Medical Center

Others

BY COMPANY

Pfizer

Novartis AG

GlaxoSmithKline

Merck

Medtronic

The Kroger Co.

Aros Pharma

AstraZeneca, Plc.

Addex Therapeutics

Takeda Pharmaceutical Company Limited

BY REGION

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

FEATURED COMPANIES

Takeda Pharmaceutical Company Limited

1 Study Coverage

1.1 Gastro Esophageal Reflux Disease (GERD) Drug Product Introduction

1.2 Market by Type

1.2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 H2 Receptor Antagonist

1.2.3 Proton Pump Inhibitor (PPi)

1.2.4 Antacids

1.3 Market by Application

1.3.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Medical Center

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Estimates and Forecasts 2017-2028

2.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Estimates and Forecasts 2017-2028

2.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region

2.4.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region (2017-2022)

2.4.2 Global Sales Gastro Esophageal Reflux Disease (GERD) Drug by Region (2023-2028)

2.5 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Region

2.5.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Region (2017-2022)

2.5.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Manufacturers

3.1.1 Global Top Gastro Esophageal Reflux Disease (GERD) Drug Manufacturers by Sales (2017-2022)

3.1.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Gastro Esophageal Reflux Disease (GERD) Drug in 2021

3.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Manufacturers

3.2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Manufacturers (2017-2022)

3.2.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Gastro Esophageal Reflux Disease (GERD) Drug Revenue in 2021

3.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type

4.1.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Historical Sales by Type (2017-2022)

4.1.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Forecasted Sales by Type (2023-2028)

4.1.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type (2017-2028)

4.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type

4.2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Historical Revenue by Type (2017-2022)

4.2.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Forecasted Revenue by Type (2023-2028)

4.2.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Type (2017-2028)

4.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Price by Type

4.3.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Price by Type (2017-2022)

4.3.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application

5.1.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Historical Sales by Application (2017-2022)

5.1.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Forecasted Sales by Application (2023-2028)

5.1.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application (2017-2028)

5.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application

5.2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Historical Revenue by Application (2017-2022)

5.2.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Forecasted Revenue by Application (2023-2028)

5.2.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Application (2017-2028)

5.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Price by Application

5.3.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Price by Application (2017-2022)

5.3.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Price Forecast by Application (2023-2028)

6 North America

6.1 North America Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Type

6.1.1 North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2017-2028)

6.1.2 North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2017-2028)

6.2 North America Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Application

6.2.1 North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2017-2028)

6.2.2 North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2017-2028)

6.3 North America Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Country

6.3.1 North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2017-2028)

6.3.2 North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country (2017-2028)

6.3.3 U.S.

6.3.4 Canada

7 Europe

7.1 Europe Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Type

7.1.1 Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2017-2028)

7.1.2 Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2017-2028)

7.2 Europe Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Application

7.2.1 Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2017-2028)

7.2.2 Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2017-2028)

7.3 Europe Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Country

7.3.1 Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2017-2028)

7.3.2 Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Type

8.1.1 Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2017-2028)

8.1.2 Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2017-2028)

8.2 Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Application

8.2.1 Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2017-2028)

8.2.2 Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2017-2028)

8.3 Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Region

8.3.1 Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region (2017-2028)

8.3.2 Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

8.3.12 Philippines

9 Latin America

9.1 Latin America Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Type

9.1.1 Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2017-2028)

9.1.2 Latin America Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2017-2028)

9.2 Latin America Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Application

9.2.1 Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2017-2028)

9.2.2 Latin America Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2017-2028)

9.3 Latin America Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Country

9.3.1 Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2017-2028)

9.3.2 Latin America Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Type

10.1.1 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2017-2028)

10.1.2 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2017-2028)

10.2 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Application

10.2.1 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2017-2028)

10.2.2 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2017-2028)

10.3 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Country

10.3.1 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2017-2028)

10.3.2 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 Pfizer

11.1.1 Pfizer Corporation Information

11.1.2 Pfizer Overview

11.1.3 Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Pfizer Recent Developments

11.2 Novartis AG

11.2.1 Novartis AG Corporation Information

11.2.2 Novartis AG Overview

11.2.3 Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Novartis AG Recent Developments

11.3 GlaxoSmithKline

11.3.1 GlaxoSmithKline Corporation Information

11.3.2 GlaxoSmithKline Overview

11.3.3 GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 GlaxoSmithKline Recent Developments

11.4 Merck

11.4.1 Merck Corporation Information

11.4.2 Merck Overview

11.4.3 Merck Gastro Esophageal Reflux Disease (GERD) Drug Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 Merck Gastro Esophageal Reflux Disease (GERD) Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Merck Recent Developments

11.5 Medtronic

11.5.1 Medtronic Corporation Information

11.5.2 Medtronic Overview

11.5.3 Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Sales, Price, Revenue and Gross Margin (2017-2022)

11.5.4 Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Medtronic Recent Developments

11.6 The Kroger Co.

11.6.1 The Kroger Co. Corporation Information

11.6.2 The Kroger Co. Overview

11.6.3 The Kroger Co. Gastro Esophageal Reflux Disease (GERD) Drug Sales, Price, Revenue and Gross Margin (2017-2022)

11.6.4 The Kroger Co. Gastro Esophageal Reflux Disease (GERD) Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 The Kroger Co. Recent Developments

11.7 Aros Pharma

11.7.1 Aros Pharma Corporation Information

11.7.2 Aros Pharma Overview

11.7.3 Aros Pharma Gastro Esophageal Reflux Disease (GERD) Drug Sales, Price, Revenue and Gross Margin (2017-2022)

11.7.4 Aros Pharma Gastro Esophageal Reflux Disease (GERD) Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Aros Pharma Recent Developments

11.8 AstraZeneca, Plc.

11.8.1 AstraZeneca, Plc. Corporation Information

11.8.2 AstraZeneca, Plc. Overview

11.8.3 AstraZeneca, Plc. Gastro Esophageal Reflux Disease (GERD) Drug Sales, Price, Revenue and Gross Margin (2017-2022)

11.8.4 AstraZeneca, Plc. Gastro Esophageal Reflux Disease (GERD) Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 AstraZeneca, Plc. Recent Developments

11.9 Addex Therapeutics

11.9.1 Addex Therapeutics Corporation Information

11.9.2 Addex Therapeutics Overview

11.9.3 Addex Therapeutics Gastro Esophageal Reflux Disease (GERD) Drug Sales, Price, Revenue and Gross Margin (2017-2022)

11.9.4 Addex Therapeutics Gastro Esophageal Reflux Disease (GERD) Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Addex Therapeutics Recent Developments

11.10 Takeda Pharmaceutical Company Limited

11.10.1 Takeda Pharmaceutical Company Limited Corporation Information

11.10.2 Takeda Pharmaceutical Company Limited Overview

11.10.3 Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease (GERD) Drug Sales, Price, Revenue and Gross Margin (2017-2022)

11.10.4 Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease (GERD) Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 Takeda Pharmaceutical Company Limited Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Gastro Esophageal Reflux Disease (GERD) Drug Industry Chain Analysis

12.2 Gastro Esophageal Reflux Disease (GERD) Drug Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Gastro Esophageal Reflux Disease (GERD) Drug Production Mode & Process

12.4 Gastro Esophageal Reflux Disease (GERD) Drug Sales and Marketing

12.4.1 Gastro Esophageal Reflux Disease (GERD) Drug Sales Channels

12.4.2 Gastro Esophageal Reflux Disease (GERD) Drug Distributors

12.5 Gastro Esophageal Reflux Disease (GERD) Drug Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Gastro Esophageal Reflux Disease (GERD) Drug Industry Trends

13.2 Gastro Esophageal Reflux Disease (GERD) Drug Market Drivers

13.3 Gastro Esophageal Reflux Disease (GERD) Drug Market Challenges

13.4 Gastro Esophageal Reflux Disease (GERD) Drug Market Restraints

14 Key Findings in The Global Gastro Esophageal Reflux Disease (GERD) Drug Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Takeda Pharmaceutical Company Limited

List of Tables

Table 1. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)

Table 2. Major Manufacturers of H2 Receptor Antagonist

Table 3. Major Manufacturers of Proton Pump Inhibitor (PPi)

Table 4. Major Manufacturers of Antacids

Table 5. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)

Table 6. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)

Table 7. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region (2017-2022) & (K Pcs)

Table 8. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Region (2017-2022)

Table 9. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region (2023-2028) & (K Pcs)

Table 10. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Region (2023-2028)

Table 11. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Region (2017-2022) & (US$ Million)

Table 12. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Region (2017-2022)

Table 13. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Region (2023-2028) & (US$ Million)

Table 14. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Region (2023-2028)

Table 15. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Manufacturers (2017-2022) & (K Pcs)

Table 16. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Share by Manufacturers (2017-2022)

Table 17. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Manufacturers (2017-2022) & (US$ Million)

Table 18. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Manufacturers (2017-2022)

Table 19. Gastro Esophageal Reflux Disease (GERD) Drug Price by Manufacturers (2017-2022) &(USD/Pcs)

Table 20. Global Gastro Esophageal Reflux Disease (GERD) Drug Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 21. Global Gastro Esophageal Reflux Disease (GERD) Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastro Esophageal Reflux Disease (GERD) Drug as of 2021)

Table 22. Gastro Esophageal Reflux Disease (GERD) Drug Manufacturing Base Distribution and Headquarters

Table 23. Manufacturers Gastro Esophageal Reflux Disease (GERD) Drug Product Offered

Table 24. Date of Manufacturers Enter into Gastro Esophageal Reflux Disease (GERD) Drug Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2017-2022) & (K Pcs)

Table 27. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2023-2028) & (K Pcs)

Table 28. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Share by Type (2017-2022)

Table 29. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Share by Type (2023-2028)

Table 30. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2017-2022) & (US$ Million)

Table 31. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2023-2028) & (US$ Million)

Table 32. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Type (2017-2022)

Table 33. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Type (2023-2028)

Table 34. Gastro Esophageal Reflux Disease (GERD) Drug Price by Type (2017-2022) & (USD/Pcs)

Table 35. Global Gastro Esophageal Reflux Disease (GERD) Drug Price Forecast by Type (2023-2028) & (USD/Pcs)

Table 36. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2017-2022) & (K Pcs)

Table 37. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2023-2028) & (K Pcs)

Table 38. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Share by Application (2017-2022)

Table 39. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Share by Application (2023-2028)

Table 40. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2017-2022) & (US$ Million)

Table 41. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2023-2028) & (US$ Million)

Table 42. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Application (2017-2022)

Table 43. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Application (2023-2028)

Table 44. Gastro Esophageal Reflux Disease (GERD) Drug Price by Application (2017-2022) & (USD/Pcs)

Table 45. Global Gastro Esophageal Reflux Disease (GERD) Drug Price Forecast by Application (2023-2028) & (USD/Pcs)

Table 46. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2017-2022) & (K Pcs)

Table 47. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2023-2028) & (K Pcs)

Table 48. North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2017-2022) & (US$ Million)

Table 49. North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2023-2028) & (US$ Million)

Table 50. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2017-2022) & (K Pcs)

Table 51. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2023-2028) & (K Pcs)

Table 52. North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2017-2022) & (US$ Million)

Table 53. North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2023-2028) & (US$ Million)

Table 54. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2017-2022) & (K Pcs)

Table 55. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2023-2028) & (K Pcs)

Table 56. North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country (2017-2022) & (US$ Million)

Table 57. North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country (2023-2028) & (US$ Million)

Table 58. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2017-2022) & (K Pcs)

Table 59. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2023-2028) & (K Pcs)

Table 60. Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2017-2022) & (US$ Million)

Table 61. Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2023-2028) & (US$ Million)

Table 62. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2017-2022) & (K Pcs)

Table 63. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2023-2028) & (K Pcs)

Table 64. Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2017-2022) & (US$ Million)

Table 65. Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2023-2028) & (US$ Million)

Table 66. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2017-2022) & (K Pcs)

Table 67. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2023-2028) & (K Pcs)

Table 68. Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country (2017-2022) & (US$ Million)

Table 69. Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country (2023-2028) & (US$ Million)

Table 70. Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2017-2022) & (K Pcs)

Table 71. Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2023-2028) & (K Pcs)

Table 72. Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2017-2022) & (US$ Million)

Table 73. Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2023-2028) & (US$ Million)

Table 74. Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2017-2022) & (K Pcs)

Table 75. Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2023-2028) & (K Pcs)

Table 76. Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2017-2022) & (US$ Million)

Table 77. Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2023-2028) & (US$ Million)

Table 78. Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region (2017-2022) & (K Pcs)

Table 79. Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region (2023-2028) & (K Pcs)

Table 80. Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Region (2017-2022) & (US$ Million)

Table 81. Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Region (2023-2028) & (US$ Million)

Table 82. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2017-2022) & (K Pcs)

Table 83. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2023-2028) & (K Pcs)

Table 84. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2017-2022) & (US$ Million)

Table 85. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2023-2028) & (US$ Million)

Table 86. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2017-2022) & (K Pcs)

Table 87. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2023-2028) & (K Pcs)

Table 88. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2017-2022) & (US$ Million)

Table 89. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2023-2028) & (US$ Million)

Table 90. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2017-2022) & (K Pcs)

Table 91. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2023-2028) & (K Pcs)

Table 92. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country (2017-2022) & (US$ Million)

Table 93. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country (2023-2028) & (US$ Million)

Table 94. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2017-2022) & (K Pcs)

Table 95. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2023-2028) & (K Pcs)

Table 96. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2017-2022) & (US$ Million)

Table 97. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2023-2028) & (US$ Million)

Table 98. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2017-2022) & (K Pcs)

Table 99. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2023-2028) & (K Pcs)

Table 100. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2017-2022) & (US$ Million)

Table 101. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2023-2028) & (US$ Million)

Table 102. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2017-2022) & (K Pcs)

Table 103. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2023-2028) & (K Pcs)

Table 104. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country (2017-2022) & (US$ Million)

Table 105. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country (2023-2028) & (US$ Million)

Table 106. Pfizer Corporation Information

Table 107. Pfizer Description and Major Businesses

Table 108. Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)

Table 109. Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 110. Pfizer Recent Developments

Table 111. Novartis AG Corporation Information

Table 112. Novartis AG Description and Major Businesses

Table 113. Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)

Table 114. Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 115. Novartis AG Recent Developments

Table 116. GlaxoSmithKline Corporation Information

Table 117. GlaxoSmithKline Description and Major Businesses

Table 118. GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)

Table 119. GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 120. GlaxoSmithKline Recent Developments

Table 121. Merck Corporation Information

Table 122. Merck Description and Major Businesses

Table 123. Merck Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)

Table 124. Merck Gastro Esophageal Reflux Disease (GERD) Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 125. Merck Recent Developments

Table 126. Medtronic Corporation Information

Table 127. Medtronic Description and Major Businesses

Table 128. Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)

Table 129. Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 130. Medtronic Recent Developments

Table 131. The Kroger Co. Corporation Information

Table 132. The Kroger Co. Description and Major Businesses

Table 133. The Kroger Co. Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)

Table 134. The Kroger Co. Gastro Esophageal Reflux Disease (GERD) Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 135. The Kroger Co. Recent Developments

Table 136. Aros Pharma Corporation Information

Table 137. Aros Pharma Description and Major Businesses

Table 138. Aros Pharma Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)

Table 139. Aros Pharma Gastro Esophageal Reflux Disease (GERD) Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 140. Aros Pharma Recent Developments

Table 141. AstraZeneca, Plc. Corporation Information

Table 142. AstraZeneca, Plc. Description and Major Businesses

Table 143. AstraZeneca, Plc. Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)

Table 144. AstraZeneca, Plc. Gastro Esophageal Reflux Disease (GERD) Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 145. AstraZeneca, Plc. Recent Developments

Table 146. Addex Therapeutics Corporation Information

Table 147. Addex Therapeutics Description and Major Businesses

Table 148. Addex Therapeutics Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)

Table 149. Addex Therapeutics Gastro Esophageal Reflux Disease (GERD) Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 150. Addex Therapeutics Recent Developments

Table 151. Takeda Pharmaceutical Company Limited Corporation Information

Table 152. Takeda Pharmaceutical Company Limited Description and Major Businesses

Table 153. Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)

Table 154. Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease (GERD) Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 155. Takeda Pharmaceutical Company Limited Recent Developments

Table 156. Key Raw Materials Lists

Table 157. Raw Materials Key Suppliers Lists

Table 158. Gastro Esophageal Reflux Disease (GERD) Drug Distributors List

Table 159. Gastro Esophageal Reflux Disease (GERD) Drug Customers List

Table 160. Gastro Esophageal Reflux Disease (GERD) Drug Market Trends

Table 161. Gastro Esophageal Reflux Disease (GERD) Drug Market Drivers

Table 162. Gastro Esophageal Reflux Disease (GERD) Drug Market Challenges

Table 163. Gastro Esophageal Reflux Disease (GERD) Drug Market Restraints

Table 164. Research Programs/Design for This Report

Table 165. Key Data Information from Secondary Sources

Table 166. Key Data Information from Primary Sources

List of Figures

Figure 1. Gastro Esophageal Reflux Disease (GERD) Drug Product Picture

Figure 3. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Share by Type in 2021 & 2028

Figure 3. H2 Receptor Antagonist Product Picture

Figure 4. Proton Pump Inhibitor (PPi) Product Picture

Figure 5. Antacids Product Picture

Figure 6. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Share by Application in 2021 & 2028

Figure 7. Hospital

Figure 8. Clinic

Figure 9. Medical Center

Figure 10. Others

Figure 11. Gastro Esophageal Reflux Disease (GERD) Drug Report Years Considered

Figure 12. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales 2017-2028 (K Pcs)

Figure 13. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028

Figure 14. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue 2017-2028 (US$ Million)

Figure 15. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028

Figure 16. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Region (2017-2022)

Figure 17. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Region (2023-2028)

Figure 18. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales YoY (2017-2028) & (K Pcs)

Figure 19. North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue YoY (2017-2028) & (US$ Million)

Figure 20. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales YoY (2017-2028) & (K Pcs)

Figure 21. Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue YoY (2017-2028) & (US$ Million)

Figure 22. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales YoY (2017-2028) & (K Pcs)

Figure 23. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Revenue YoY (2017-2028) & (US$ Million)

Figure 24. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales YoY (2017-2028) & (K Pcs)

Figure 25. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Revenue YoY (2017-2028) & (US$ Million)

Figure 26. Middle East & Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales YoY (2017-2028) & (K Pcs)

Figure 27. Middle East & Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue YoY (2017-2028) & (US$ Million)

Figure 28. The Gastro Esophageal Reflux Disease (GERD) Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021

Figure 29. The Top 5 and 10 Largest Manufacturers of Gastro Esophageal Reflux Disease (GERD) Drug in the World: Market Share by Gastro Esophageal Reflux Disease (GERD) Drug Revenue in 2021

Figure 30. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021

Figure 31. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type (2017-2028)

Figure 32. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Type (2017-2028)

Figure 33. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application (2017-2028)

Figure 34. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Application (2017-2028)

Figure 35. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type (2017-2028)

Figure 36. North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Type (2017-2028)

Figure 37. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application (2017-2028)

Figure 38. North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Application (2017-2028)

Figure 39. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales Share by Country (2017-2028)

Figure 40. North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Country (2017-2028)

Figure 41. U.S. Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2017-2028) & (US$ Million)

Figure 42. Canada Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2017-2028) & (US$ Million)

Figure 43. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type (2017-2028)

Figure 44. Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Type (2017-2028)

Figure 45. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application (2017-2028)

Figure 46. Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Application (2017-2028)

Figure 47. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Share by Country (2017-2028)

Figure 48. Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Country (2017-2028)

Figure 49. Germany Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2017-2028) & (US$ Million)

Figure 50. France Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2017-2028) & (US$ Million)

Figure 51. U.K. Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2017-2028) & (US$ Million)

Figure 52. Italy Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2017-2028) & (US$ Million)

Figure 53. Russia Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2017-2028) & (US$ Million)

Figure 54. Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type (2017-2028)

Figure 55. Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Type (2017-2028)

Figure 56. Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application (2017-2028)

Figure 57. Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Application (2017-2028)

Figure 58. Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales Share by Region (2017-2028)

Figure 59. Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Region (2017-2028)

Figure 60. China Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2017-2028) & (US$ Million)

Figure 61. Japan Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2017-2028) & (US$ Million)

Figure 62. South Korea Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2017-2028) & (US$ Million)

Figure 63. India Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2017-2028) & (US$ Million)

Figure 64. Australia Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2017-2028) & (US$ Million)

Figure 65. Taiwan Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2017-2028) & (US$ Million)

Figure 66. Indonesia Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2017-2028) & (US$ Million)

Figure 67. Thailand Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2017-2028) & (US$ Million)

Figure 68. Malaysia Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2017-2028) & (US$ Million)

Figure 69. Philippines Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2017-2028) & (US$ Million)

Figure 70. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type (2017-2028)

Figure 71. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Type (2017-2028)

Figure 72. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application (2017-2028)

Figure 73. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Application (2017-2028)

Figure 74. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales Share by Country (2017-2028)

Figure 75. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Country (2017-2028)

Figure 76. Mexico Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2017-2028) & (US$ Million)

Figure 77. Brazil Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2017-2028) & (US$ Million)

Figure 78. Argentina Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2017-2028) & (US$ Million)

Figure 79. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type (2017-2028)

Figure 80. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Type (2017-2028)

Figure 81. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application (2017-2028)

Figure 82. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Application (2017-2028)

Figure 83. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales Share by Country (2017-2028)

Figure 84. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Country (2017-2028)

Figure 85. Turkey Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2017-2028) & (US$ Million)

Figure 86. Saudi Arabia Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2017-2028) & (US$ Million)

Figure 87. U.A.E Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2017-2028) & (US$ Million)

Figure 88. Gastro Esophageal Reflux Disease (GERD) Drug Value Chain

Figure 89. Gastro Esophageal Reflux Disease (GERD) Drug Production Process

Figure 90. Channels of Distribution

Figure 91. Distributors Profiles

Figure 92. Bottom-up and Top-down Approaches for This Report

Figure 93. Data Triangulation

Figure 94. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Gastro Esophageal Reflux Disease (GERD) Drug Market Insights and Forecast to 2028

Published Date: January 2022

Report Code: QYRE-Auto-15V9374

Global Gastro Esophageal Reflux Disease (GERD) Drug Market Insights and Forecast to 2028

FEATURED COMPANIES

Segment by Type

Segment by Application

BY COMPANY

BY REGION

FEATURED COMPANIES

FEATURED COMPANIES

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-39D3651

Wed Apr 17 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-24F2529

Wed Apr 17 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-31C5944

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-10J13802

Mon Apr 15 00:00:00 UTC 2024

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions